Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00972153 · ClinicalTrials.gov registry record · NA

Device to Reduce Surgery Site Contamination

A NA study of Surgery, sponsored by Nimbic Systems.

Completed
Registry status
NA
Development phase
29
Enrollment target
1
Study location

NCT00972153 is a NA study of Surgery that has completed, run by Nimbic Systems. The registered enrollment target is 29 participants, below the 52,852-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00972153, a NA study of Surgery, has completed, sponsored by Nimbic Systems.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to determine whether the Air Barrier System device reduces airborne particulate and airborne colony forming units present at a surgery site.

Conditions Studied

Interventions

  • DEVICE Air Barrier System Device
  • DEVICE Sham Air Barrier System device

Study Locations (1)

Texas

  • Texas Orthopedic Hospital - Houston

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2009-05
Est. Completion 2009-09
Phase NA

Sponsor

Nimbic Systems

4 total trials

What the Registry Record Tells You About NCT00972153

The ClinicalTrials.gov registry entry for NCT00972153 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 52,852-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The listed sponsor is Nimbic Systems, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Surgery appearing as the primary indexed condition, and to 2 interventions - of which Air Barrier System Device is the first listed.

NCT00972153 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00972153 about?

NCT00972153 is a clinical study titled "Device to Reduce Surgery Site Contamination". The objective of this study is to determine whether the Air Barrier System device reduces airborne particulate and airborne colony forming units present at a surgery site.

What is the current status of trial NCT00972153?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2009-05. Estimated completion is 2009-09.

What conditions does trial NCT00972153 study?

This clinical trial studies the following conditions: Surgery.

What interventions are being tested in trial NCT00972153?

The interventions under investigation include: Air Barrier System Device (DEVICE), Sham Air Barrier System device (DEVICE).

Who is sponsoring clinical trial NCT00972153?

This trial is sponsored by Nimbic Systems, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00972153 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.